NCT02963389 2019-01-15
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
Dong-A ST Co., Ltd.
Phase 1 Completed
Dong-A ST Co., Ltd.
Sanofi
Dong-A ST Co., Ltd.
Dong-A ST Co., Ltd.